Researchers at King's College London found that biological age measured through blood metabolites can predict the risk of all-cause dementia [1].
This discovery is significant because it offers a potential early warning system for cognitive decline. By identifying risk in midlife, clinicians may be able to implement interventions before irreversible brain damage occurs [3].
Biological age differs from chronological age by reflecting how organs and systems have actually aged [2]. While a person's birth date is fixed, the state of their blood metabolites provides a snapshot of organ-level aging [3]. The study, published by the Alzheimer's Association, suggests that this biological marker is a stronger predictor of dementia than age alone [1].
According to the research, the blood-based measure is particularly effective when combined with known genetic factors [1]. This combined approach allows for a more precise risk profile, helping to distinguish between those who are biologically older than their years and those who are not [2].
The findings focus on patterns of metabolites in the blood that signal systemic aging [3]. Because these changes often occur years before the first signs of memory loss, the test could serve as a critical screening tool in the United Kingdom and beyond [2].
Researchers said the method focuses on the biological reality of the body rather than the calendar [3]. This shift in focus allows for a more personalized approach to brain health and preventative care [1].
“Biological age reflects organ-level aging beyond chronological age.”
The transition from chronological to biological age markers represents a shift toward precision medicine in neurology. If blood metabolite testing becomes a clinical standard, it could allow healthcare providers to categorize patients by their actual physiological risk rather than relying on broad age brackets, potentially accelerating the identification of high-risk individuals for clinical trials and preventative therapies.
